Correction to "Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213".
作者信息
Denisov Ilia G, Grinkova Yelena V, Nandigrami Prithviraj, Shekhar Mrinal, Tajkhorshid Emad, Sligar Stephen G
出版信息
Biochemistry. 2019 Jun 18;58(24):2796. doi: 10.1021/acs.biochem.9b00438. Epub 2019 Jun 6.
Abstract
摘要
相似文献
1
Correction to "Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213".《人类细胞色素P450 CYP3A4中的变构相互作用：苯丙氨酸213的作用》的勘误
Biochemistry. 2019 Jun 18;58(24):2796. doi: 10.1021/acs.biochem.9b00438. Epub 2019 Jun 6.
2
Allosteric Interactions in Human Cytochrome P450 CYP3A4: The Role of Phenylalanine 213.变构相互作用在人细胞色素 P450 CYP3A4 中的作用：苯丙氨酸 213 的作用。
Biochemistry. 2019 Mar 12;58(10):1411-1422. doi: 10.1021/acs.biochem.8b01268. Epub 2019 Feb 28.
3
The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.使用异构睾酮二聚体来探究底物与细胞色素P450 CYP3A4结合中的变构效应。
J Inorg Biochem. 2016 May;158:77-85. doi: 10.1016/j.jinorgbio.2015.12.019. Epub 2015 Dec 31.
4
Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation.通过孕酮生物共轭实现细胞色素P450 3A4的变构激活
Bioconjug Chem. 2017 Apr 19;28(4):885-889. doi: 10.1021/acs.bioconjchem.6b00604. Epub 2017 Mar 29.
5
Allosteric mechanisms in cytochrome P450 3A4 studied by high-pressure spectroscopy: pivotal role of substrate-induced changes in the accessibility and degree of hydration of the heme pocket.通过高压光谱研究细胞色素P450 3A4中的变构机制：底物诱导的血红素口袋可及性和水合程度变化的关键作用。
Biochemistry. 2007 Jul 3;46(26):7852-64. doi: 10.1021/bi602400y. Epub 2007 Jun 8.
6
Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone.与美替拉酮和孕酮结合的人细胞色素P450 3A4的晶体结构。
Science. 2004 Jul 30;305(5684):683-6. doi: 10.1126/science.1099736. Epub 2004 Jul 15.
7
Role of cytochrome B5 in modulating peroxide-supported cyp3a4 activity: evidence for a conformational transition and cytochrome P450 heterogeneity.细胞色素B5在调节过氧化物支持的CYP3A4活性中的作用：构象转变和细胞色素P450异质性的证据。
Drug Metab Dispos. 2005 Aug;33(8):1131-6. doi: 10.1124/dmd.105.004606. Epub 2005 May 3.
8
Coexpression of genetically engineered fused enzyme between yeast NADPH-P450 reductase and human cytochrome P450 3A4 and human cytochrome b5 in yeast.酵母中基因工程改造的酵母NADPH-P450还原酶与人细胞色素P450 3A4及人细胞色素b5之间的融合酶的共表达。
Arch Biochem Biophys. 2000 Sep 1;381(1):164-70. doi: 10.1006/abbi.2000.1953.
9
10
Evaluation of in vitro cytochrome P450 induction and inhibition activity of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber L.评估地胆苦素，一种来自地胆草的倍半萜内酯，对细胞色素 P450 的体外诱导和抑制活性。
Food Chem Toxicol. 2013 Oct;60:98-108. doi: 10.1016/j.fct.2013.07.030. Epub 2013 Jul 20.
引用本文的文献
1
Profiling the Tox21 Compound Library for Their Inhibitory Effects on Cytochrome P450 Enzymes.分析Tox21化合物库对细胞色素P450酶的抑制作用。
Int J Mol Sci. 2025 May 22;26(11):4976. doi: 10.3390/ijms26114976.
本文引用的文献
1
Steroid bioconjugation to a CYP3A4 allosteric site and its effect on substrate binding and coupling efficiency.甾体化合物与 CYP3A4 变构部位的生物缀合及其对底物结合和偶联效率的影响。
Arch Biochem Biophys. 2018 Sep 1;653:90-96. doi: 10.1016/j.abb.2018.06.014. Epub 2018 Jun 26.
2
Human Cytochrome CYP17A1: The Structural Basis for Compromised Lyase Activity with 17-Hydroxyprogesterone.人细胞色素 CYP17A1：与 17-羟孕酮的裂解酶活性受损的结构基础。
J Am Chem Soc. 2018 Jun 13;140(23):7324-7331. doi: 10.1021/jacs.8b03901. Epub 2018 Jun 5.
3
Drug-Drug Interactions between Atorvastatin and Dronedarone Mediated by Monomeric CYP3A4.由单体CYP3A4介导的阿托伐他汀与决奈达隆之间的药物相互作用。
Biochemistry. 2018 Feb 6;57(5):805-816. doi: 10.1021/acs.biochem.7b01012. Epub 2017 Dec 14.
4
Allosteric Activation of Cytochrome P450 3A4 via Progesterone Bioconjugation.通过孕酮生物共轭实现细胞色素P450 3A4的变构激活
Bioconjug Chem. 2017 Apr 19;28(4):885-889. doi: 10.1021/acs.bioconjchem.6b00604. Epub 2017 Mar 29.
5
Nanodiscs in Membrane Biochemistry and Biophysics.膜生物化学与生物物理学中的纳米圆盘
Chem Rev. 2017 Mar 22;117(6):4669-4713. doi: 10.1021/acs.chemrev.6b00690. Epub 2017 Feb 8.
6
The use of isomeric testosterone dimers to explore allosteric effects in substrate binding to cytochrome P450 CYP3A4.使用异构睾酮二聚体来探究底物与细胞色素P450 CYP3A4结合中的变构效应。
J Inorg Biochem. 2016 May;158:77-85. doi: 10.1016/j.jinorgbio.2015.12.019. Epub 2015 Dec 31.
7
Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.基于结构的抑制剂设计用于评估CYP3A4药效团模型。
J Med Chem. 2016 May 12;59(9):4210-20. doi: 10.1021/acs.jmedchem.5b01146. Epub 2015 Sep 24.
8
Physiologically based pharmacokinetic modeling of disposition and drug-drug interactions for atorvastatin and its metabolites.阿托伐他汀及其代谢产物的处置和药物相互作用的基于生理的药代动力学建模。
Eur J Pharm Sci. 2015 Sep 18;77:216-29. doi: 10.1016/j.ejps.2015.06.019. Epub 2015 Jun 24.
9
Mechanism of drug-drug interactions mediated by human cytochrome P450 CYP3A4 monomer.由人细胞色素P450 CYP3A4单体介导的药物相互作用机制。
Biochemistry. 2015 Apr 7;54(13):2227-39. doi: 10.1021/acs.biochem.5b00079. Epub 2015 Mar 25.
10
Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.受分子动力学模拟启发，细胞色素P450 3A4活性位点突变体催化卡马西平环氧化反应中的协同作用与底物抑制作用
Biochemistry. 2015 Jan 27;54(3):711-21. doi: 10.1021/bi5011656. Epub 2015 Jan 15.
Zotero 插件